Schonfeld Strategic Advisors LLC Alaunos Therapeutics, Inc. Transaction History

Schonfeld Strategic Advisors LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$1.04 - $322.5 $44,138 - $13.7 Million	42,441 New	42,441 $73,000
Q1 2021 May 17, 2021	SELL	$2.82 - $5.6 $40,362 - $80,152	-14,313 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$2.09 - $3.09 $105,143 - $155,451	-50,308 Reduced 77.85%	14,313 $36,000
Q3 2020 Nov 16, 2020	SELL	$2.39 - $3.43 $70,440 - $101,092	-29,473 Reduced 31.32%	64,621 $0
Q2 2020 Aug 14, 2020	BUY	$2.2 - $3.71 $207,006 - $349,088	94,094 New	94,094 $308,000

92.6K

Ticker TCRT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,182,000
Market Cap $443M
Description
Alaunos Therapeutics, Inc., a clinical-stage oncology-focused cell therapy company, develops adoptive TCR engineered T-cell therapies. It develops TCR Library, which is in Phase I/II clinical trial for ten TCRs reactive to mutated KRAS, TP53, and EGFR from its TCR library for the treatment of non-small cell lung, colorectal, endometrial, pancrea...

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.